Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-046461

Chief Legal Officer sold 7,221 shares at $0.78 ($5,632)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew Chief Legal Officer 2023-08-16 Sale −7,221 $0.78 $5,632 250,959 D
Open-market sales · 7,221 sh · avg $0.78 · $5,632
Loading xslF345X05/doc4.xml…